DVL2 and cancer: Six genes (PDXDC1, ATF7IP2, LIN7C JTB, TTL, DVL2), which regulate the ERG signal transduction pathways, were retained in 4 out of 9 LT patients, were significantly involved in transcriptional mis-regulation in cancer (multiple testing adjusted p-value = 0.025).